Chronic Obstructive Pulmonary Disease Biomarkers
Despite significant decreases in morbidity and mortality of cardiovascular diseases (CVD) and cancers, morbidity and cost associated with chronic obstructive pulmonary disease (COPD) continue to be increasing. Failure to improve disease outcomes has been related to the paucity of interventions impro...
Main Authors: | Tatsiana Beiko, Charlie Strange |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-04-01
|
Series: | Eurasian Journal of Pulmonology |
Subjects: | |
Online Access: | http://www.journalagent.com/z4/download_fulltext.asp?pdir=eurasianjpulmonol&plng=eng&un=EJP-02411 |
Similar Items
-
Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease
by: Balmes John, et al.
Published: (2005-05-01) -
Autoantibodies in Chronic Obstructive Pulmonary Disease
by: Lifang Wen, et al.
Published: (2018-01-01) -
Endothelium-related and neuro-mediated mechanisms of emphysema development in chronic obstructive pulmonary disease
by: T. A. Brodskaya, et al.
Published: (2020-03-01) -
A study of chronic obstructive pulmonary disease-specific causes of osteoporosis with emphasis on the emphysema phenotype
by: Mona Ali Fouda, et al.
Published: (2017-01-01) -
The genetics of chronic obstructive pulmonary disease
by: Silverman Edwin K, et al.
Published: (2001-01-01)